Report Detail

Request for Sample of this report

Medical Industry Global AI-driven Drug Discovery Market Growth (Status and Outlook) 2023-2029

  • RnM4502126
    • |
  • 13 January, 2023
    • |
  • Global
    • |
  • 113 Pages
    • |
  • LPI(LP Information)
    • |
  • Medical Industry

AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials.

Newest research report, the “AI-driven Drug Discovery Industry Forecast” looks at past sales and reviews total world AI-driven Drug Discovery sales in 2022, providing a comprehensive analysis by region and market sector of projected AI-driven Drug Discovery sales for 2023 through 2029. With AI-driven Drug Discovery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI-driven Drug Discovery industry.

This Insight Report provides a comprehensive analysis of the global AI-driven Drug Discovery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on AI-driven Drug Discovery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI-driven Drug Discovery market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI-driven Drug Discovery and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI-driven Drug Discovery.

The global AI-driven Drug Discovery market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for AI-driven Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for AI-driven Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for AI-driven Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key AI-driven Drug Discovery players cover Entos, Selvita, Benevolent, Exscientia, Euretos, Illumina with AstraZeneca, Novo Nordisk with Microsoft, Iktos and Aqemia, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of AI-driven Drug Discovery market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
Small Molecule Drug
Biological Modeling
Structural Biology
Others

Segmentation by application
Pharmaceutical and Biotechnology Companies
Research Laboratories

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Entos
Selvita
Benevolent
Exscientia
Euretos
Illumina with AstraZeneca
Novo Nordisk with Microsoft
Iktos
Aqemia
Zephyr AI
Cyclicarx
Eli Lilly
Terray Therapeutics
Ardigen
ReviveMed
Insilico Medicine
XtalPi
MindRank
DP Technology


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global AI-driven Drug Discovery Market Size 2018-2029
    • 2.1.2 AI-driven Drug Discovery Market Size CAGR by Region 2018 VS 2022 VS 2029
  • 2.2 AI-driven Drug Discovery Segment by Type
    • 2.2.1 Small Molecule Drug
    • 2.2.2 Biological Modeling
    • 2.2.3 Structural Biology
    • 2.2.4 Others
  • 2.3 AI-driven Drug Discovery Market Size by Type
    • 2.3.1 AI-driven Drug Discovery Market Size CAGR by Type (2018 VS 2022 VS 2029)
    • 2.3.2 Global AI-driven Drug Discovery Market Size Market Share by Type (2018-2023)
  • 2.4 AI-driven Drug Discovery Segment by Application
    • 2.4.1 Pharmaceutical and Biotechnology Companies
    • 2.4.2 Research Laboratories
  • 2.5 AI-driven Drug Discovery Market Size by Application
    • 2.5.1 AI-driven Drug Discovery Market Size CAGR by Application (2018 VS 2022 VS 2029)
    • 2.5.2 Global AI-driven Drug Discovery Market Size Market Share by Application (2018-2023)

3 AI-driven Drug Discovery Market Size by Player

  • 3.1 AI-driven Drug Discovery Market Size Market Share by Players
    • 3.1.1 Global AI-driven Drug Discovery Revenue by Players (2018-2023)
    • 3.1.2 Global AI-driven Drug Discovery Revenue Market Share by Players (2018-2023)
  • 3.2 Global AI-driven Drug Discovery Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 AI-driven Drug Discovery by Regions

  • 4.1 AI-driven Drug Discovery Market Size by Regions (2018-2023)
  • 4.2 Americas AI-driven Drug Discovery Market Size Growth (2018-2023)
  • 4.3 APAC AI-driven Drug Discovery Market Size Growth (2018-2023)
  • 4.4 Europe AI-driven Drug Discovery Market Size Growth (2018-2023)
  • 4.5 Middle East & Africa AI-driven Drug Discovery Market Size Growth (2018-2023)

5 Americas

  • 5.1 Americas AI-driven Drug Discovery Market Size by Country (2018-2023)
  • 5.2 Americas AI-driven Drug Discovery Market Size by Type (2018-2023)
  • 5.3 Americas AI-driven Drug Discovery Market Size by Application (2018-2023)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC AI-driven Drug Discovery Market Size by Region (2018-2023)
  • 6.2 APAC AI-driven Drug Discovery Market Size by Type (2018-2023)
  • 6.3 APAC AI-driven Drug Discovery Market Size by Application (2018-2023)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe AI-driven Drug Discovery by Country (2018-2023)
  • 7.2 Europe AI-driven Drug Discovery Market Size by Type (2018-2023)
  • 7.3 Europe AI-driven Drug Discovery Market Size by Application (2018-2023)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa AI-driven Drug Discovery by Region (2018-2023)
  • 8.2 Middle East & Africa AI-driven Drug Discovery Market Size by Type (2018-2023)
  • 8.3 Middle East & Africa AI-driven Drug Discovery Market Size by Application (2018-2023)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global AI-driven Drug Discovery Market Forecast

  • 10.1 Global AI-driven Drug Discovery Forecast by Regions (2024-2029)
    • 10.1.1 Global AI-driven Drug Discovery Forecast by Regions (2024-2029)
    • 10.1.2 Americas AI-driven Drug Discovery Forecast
    • 10.1.3 APAC AI-driven Drug Discovery Forecast
    • 10.1.4 Europe AI-driven Drug Discovery Forecast
    • 10.1.5 Middle East & Africa AI-driven Drug Discovery Forecast
  • 10.2 Americas AI-driven Drug Discovery Forecast by Country (2024-2029)
    • 10.2.1 United States AI-driven Drug Discovery Market Forecast
    • 10.2.2 Canada AI-driven Drug Discovery Market Forecast
    • 10.2.3 Mexico AI-driven Drug Discovery Market Forecast
    • 10.2.4 Brazil AI-driven Drug Discovery Market Forecast
  • 10.3 APAC AI-driven Drug Discovery Forecast by Region (2024-2029)
    • 10.3.1 China AI-driven Drug Discovery Market Forecast
    • 10.3.2 Japan AI-driven Drug Discovery Market Forecast
    • 10.3.3 Korea AI-driven Drug Discovery Market Forecast
    • 10.3.4 Southeast Asia AI-driven Drug Discovery Market Forecast
    • 10.3.5 India AI-driven Drug Discovery Market Forecast
    • 10.3.6 Australia AI-driven Drug Discovery Market Forecast
  • 10.4 Europe AI-driven Drug Discovery Forecast by Country (2024-2029)
    • 10.4.1 Germany AI-driven Drug Discovery Market Forecast
    • 10.4.2 France AI-driven Drug Discovery Market Forecast
    • 10.4.3 UK AI-driven Drug Discovery Market Forecast
    • 10.4.4 Italy AI-driven Drug Discovery Market Forecast
    • 10.4.5 Russia AI-driven Drug Discovery Market Forecast
  • 10.5 Middle East & Africa AI-driven Drug Discovery Forecast by Region (2024-2029)
    • 10.5.1 Egypt AI-driven Drug Discovery Market Forecast
    • 10.5.2 South Africa AI-driven Drug Discovery Market Forecast
    • 10.5.3 Israel AI-driven Drug Discovery Market Forecast
    • 10.5.4 Turkey AI-driven Drug Discovery Market Forecast
    • 10.5.5 GCC Countries AI-driven Drug Discovery Market Forecast
  • 10.6 Global AI-driven Drug Discovery Forecast by Type (2024-2029)
  • 10.7 Global AI-driven Drug Discovery Forecast by Application (2024-2029)

11 Key Players Analysis

  • 11.1 Entos
    • 11.1.1 Entos Company Information
    • 11.1.2 Entos AI-driven Drug Discovery Product Offered
    • 11.1.3 Entos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.1.4 Entos Main Business Overview
    • 11.1.5 Entos Latest Developments
  • 11.2 Selvita
    • 11.2.1 Selvita Company Information
    • 11.2.2 Selvita AI-driven Drug Discovery Product Offered
    • 11.2.3 Selvita AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.2.4 Selvita Main Business Overview
    • 11.2.5 Selvita Latest Developments
  • 11.3 Benevolent
    • 11.3.1 Benevolent Company Information
    • 11.3.2 Benevolent AI-driven Drug Discovery Product Offered
    • 11.3.3 Benevolent AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.3.4 Benevolent Main Business Overview
    • 11.3.5 Benevolent Latest Developments
  • 11.4 Exscientia
    • 11.4.1 Exscientia Company Information
    • 11.4.2 Exscientia AI-driven Drug Discovery Product Offered
    • 11.4.3 Exscientia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.4.4 Exscientia Main Business Overview
    • 11.4.5 Exscientia Latest Developments
  • 11.5 Euretos
    • 11.5.1 Euretos Company Information
    • 11.5.2 Euretos AI-driven Drug Discovery Product Offered
    • 11.5.3 Euretos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.5.4 Euretos Main Business Overview
    • 11.5.5 Euretos Latest Developments
  • 11.6 Illumina with AstraZeneca
    • 11.6.1 Illumina with AstraZeneca Company Information
    • 11.6.2 Illumina with AstraZeneca AI-driven Drug Discovery Product Offered
    • 11.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.6.4 Illumina with AstraZeneca Main Business Overview
    • 11.6.5 Illumina with AstraZeneca Latest Developments
  • 11.7 Novo Nordisk with Microsoft
    • 11.7.1 Novo Nordisk with Microsoft Company Information
    • 11.7.2 Novo Nordisk with Microsoft AI-driven Drug Discovery Product Offered
    • 11.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.7.4 Novo Nordisk with Microsoft Main Business Overview
    • 11.7.5 Novo Nordisk with Microsoft Latest Developments
  • 11.8 Iktos
    • 11.8.1 Iktos Company Information
    • 11.8.2 Iktos AI-driven Drug Discovery Product Offered
    • 11.8.3 Iktos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.8.4 Iktos Main Business Overview
    • 11.8.5 Iktos Latest Developments
  • 11.9 Aqemia
    • 11.9.1 Aqemia Company Information
    • 11.9.2 Aqemia AI-driven Drug Discovery Product Offered
    • 11.9.3 Aqemia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.9.4 Aqemia Main Business Overview
    • 11.9.5 Aqemia Latest Developments
  • 11.10 Zephyr AI
    • 11.10.1 Zephyr AI Company Information
    • 11.10.2 Zephyr AI AI-driven Drug Discovery Product Offered
    • 11.10.3 Zephyr AI AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.10.4 Zephyr AI Main Business Overview
    • 11.10.5 Zephyr AI Latest Developments
  • 11.11 Cyclicarx
    • 11.11.1 Cyclicarx Company Information
    • 11.11.2 Cyclicarx AI-driven Drug Discovery Product Offered
    • 11.11.3 Cyclicarx AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.11.4 Cyclicarx Main Business Overview
    • 11.11.5 Cyclicarx Latest Developments
  • 11.12 Eli Lilly
    • 11.12.1 Eli Lilly Company Information
    • 11.12.2 Eli Lilly AI-driven Drug Discovery Product Offered
    • 11.12.3 Eli Lilly AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.12.4 Eli Lilly Main Business Overview
    • 11.12.5 Eli Lilly Latest Developments
  • 11.13 Terray Therapeutics
    • 11.13.1 Terray Therapeutics Company Information
    • 11.13.2 Terray Therapeutics AI-driven Drug Discovery Product Offered
    • 11.13.3 Terray Therapeutics AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.13.4 Terray Therapeutics Main Business Overview
    • 11.13.5 Terray Therapeutics Latest Developments
  • 11.14 Ardigen
    • 11.14.1 Ardigen Company Information
    • 11.14.2 Ardigen AI-driven Drug Discovery Product Offered
    • 11.14.3 Ardigen AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.14.4 Ardigen Main Business Overview
    • 11.14.5 Ardigen Latest Developments
  • 11.15 ReviveMed
    • 11.15.1 ReviveMed Company Information
    • 11.15.2 ReviveMed AI-driven Drug Discovery Product Offered
    • 11.15.3 ReviveMed AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.15.4 ReviveMed Main Business Overview
    • 11.15.5 ReviveMed Latest Developments
  • 11.16 Insilico Medicine
    • 11.16.1 Insilico Medicine Company Information
    • 11.16.2 Insilico Medicine AI-driven Drug Discovery Product Offered
    • 11.16.3 Insilico Medicine AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.16.4 Insilico Medicine Main Business Overview
    • 11.16.5 Insilico Medicine Latest Developments
  • 11.17 XtalPi
    • 11.17.1 XtalPi Company Information
    • 11.17.2 XtalPi AI-driven Drug Discovery Product Offered
    • 11.17.3 XtalPi AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.17.4 XtalPi Main Business Overview
    • 11.17.5 XtalPi Latest Developments
  • 11.18 MindRank
    • 11.18.1 MindRank Company Information
    • 11.18.2 MindRank AI-driven Drug Discovery Product Offered
    • 11.18.3 MindRank AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.18.4 MindRank Main Business Overview
    • 11.18.5 MindRank Latest Developments
  • 11.19 DP Technology
    • 11.19.1 DP Technology Company Information
    • 11.19.2 DP Technology AI-driven Drug Discovery Product Offered
    • 11.19.3 DP Technology AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
    • 11.19.4 DP Technology Main Business Overview
    • 11.19.5 DP Technology Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on AI-driven Drug Discovery. Industry analysis & Market Report on AI-driven Drug Discovery is a syndicated market report, published as Global AI-driven Drug Discovery Market Growth (Status and Outlook) 2023-2029. It is complete Research Study and Industry Analysis of AI-driven Drug Discovery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,829.18
5,658.36
3,407.46
6,814.92
558,845.40
1,117,690.80
308,904.00
617,808.00
Credit card Logo
Sample Question Discount Download PDF

Related Reports

Reason to Buy

  • Trusted By Leaders

    Top executives from leading companies purchase research reports from us. 

  • Shop With Confidence

    We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

  • Customer Centric

    Need assistance related to your research requirements? We are just a phone call or an email away.

  • Personalized Solutions

    Our experienced research specialists are here to help you locate the right reports for your need.

  • Secure Checkout

    Shop without being worried about safety & security of your transactions.
    •

Request for Sample of this report

Reports and Markets

mcafree

Contact Us

+1-352-353-0818 (US)

info@reportsandmarkets.com

Support

EMAIL US

Newsletter

KEEP UP TO DATE ON ALL THE LATEST REPORTS


maxmind_logo